HomeAI · summaries
Storia in 2 fonti
What's Going on With Alkermes Stock Monday? - Alkermes (NASDAQ:ALKS)
Alkermes reports positive long-term data for alixorexton, showing sustained wakefulness and symptom improvements in NT1 and NT2 narcolepsy.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension…
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
- ·
benzinga.com
What's Going on With Alkermes Stock Monday? - Alkermes (NASDAQ:ALKS)
Alkermes reports positive long-term data for alixorexton, showing sustained wakefulness and symptom improvements in NT1 and NT2 narcolepsy.